TickerFacts.

Anika Therapeutics, Inc. (ANIK): Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$112.82M
Year ended 2025-12-31
$120.65M
Trailing 12 months to 2026-06-30
-0.3%
3-year compound annual growth
$147.79M2009-12-31: $40.14M2010-12-31: $55.56M2011-12-31: $64.78M2012-12-31: $71.36M2013-12-31: $75.08M2014-12-31: $105.59M2015-12-31: $93.00M2016-12-31: $103.38M2017-12-31: $113.42M2018-12-31: $105.56M2019-12-31: $114.61M2020-12-31: $130.46M2021-12-31: $147.79M2022-12-31: $113.83M2023-12-31: $120.79M2024-12-31: $119.91M2025-12-31: $112.82M$112.82M
2009-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$112.82M-5.9%2026-03-03, From 2025-01-01
2024-12-31$119.91M-0.7%2026-03-03, From 2024-01-01
2023-12-31$120.79M+6.1%2026-03-03, From 2023-01-01
2022-12-31$113.83Mn/c2025-03-17, From 2022-01-01
2021-12-31$147.79M+13.3%2024-03-15, From 2021-01-01
2020-12-31$130.46M+13.8%2023-03-16, From 2020-01-01
2019-12-31$114.61M+8.6%2022-03-11, From 2019-01-01
2018-12-31$105.56M-6.9%2021-04-26, From 2018-01-01
2017-12-31$113.42M+9.7%2020-03-06, From 2017-01-01
2016-12-31$103.38M+11.2%2019-02-27, From 2016-01-01
2015-12-31$93.00M-11.9%2018-02-27, From 2015-01-01
2014-12-31$105.59M+40.6%2017-02-24, From 2014-01-01
2013-12-31$75.08M+5.2%2016-03-10, From 2013-01-01
2012-12-31$71.36M+10.2%2015-03-13, From 2012-01-01
2011-12-31$64.78M+16.6%2014-03-13, From 2011-01-01
2010-12-31$55.56M+38.4%2013-03-14, From 2010-01-01
2009-12-31$40.14Mn/a2012-03-13, From 2009-01-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Anika Therapeutics, Inc. (ANIK)2025-12-31$112.82M-5.9%
Orasure Technologies Inc (OSUR)2025-12-31$115.02M-38.1%
Beta Bionics, Inc. (BBNX)2025-12-31$100.25M+53.9%
NeuroPace Inc (NPCE)2025-12-31$99.99M+25.1%
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$95.13M+59.0%
Xtant Medical Holdings, Inc. (XTNT)2025-12-31$133.93M+14.2%
Pulmonx Corp (LUNG)2025-12-31$90.50M+8.0%
InfuSystem Holdings, Inc (INFU)2025-12-31$143.44M+6.4%
Neuronetics, Inc. (STIM)2025-12-31$149.16M+99.2%

Compare ANIK, OSUR, BBNX, NPCE side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗